α-Galactosylceramide and its analog OCH differentially affect the pathogenesis of ISO-induced cardiac injury in mice-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

α-Galactosylceramide and its analog OCH differentially affect the pathogenesis of ISO-induced cardiac injury in mice

Published:2020-09-24 Issue:11 Volume:41 Page:1416-1426
ISSN:1671-4083
Container-title:Acta Pharmacologica Sinica
language:en
Short-container-title:Acta Pharmacol Sin

Author:

Chen Xin,Liu Jie,Liu Jie,Wang Wen-jia,Lai Wen-jing,Li Shu-hui,Deng Ya-fei,Zhou Jian-zhi,Yang Sheng-qian,Liu Ying,Shou Wei-nian,Cao Da-yan,Li Xiao-hui

Publisher

Springer Science and Business Media LLC

Subject

Pharmacology (medical),Pharmacology,General Medicine

Link

https://www.nature.com/articles/s41401-020-00517-z.pdf

Reference51 articles.

1. Zheng PP, Li J, Kros JM. Breakthroughs in modern cancer therapy and elusive cardiotoxicity: critical research-practice gaps, challenges, and insights. Med Res Rev. 2018;38:325–76.

2. Totzeck M, Schuler M, Stuschke M, Heusch G, Rassaf T. Cardio-oncology—strategies for management of cancer-therapy related cardiovascular disease. Int J Cardiol. 2019;280:163–75.

3. Doroshow JH. Doxorubicin-induced cardiac toxicity. N Engl J Med. 1991;324:843–5.

4. Roth ME, Muluneh B, Jensen BC, Madamanchi C, Lee CB. Left ventricular dysfunction after treatment with ipilimumab for metastatic melanoma. Am J Ther. 2016;23:e1925–8.

5. Matson DR, Accola MA, Rehrauer WM, Corliss RF. Fatal myocarditis following treatment with the PD-1 inhibitor nivolumab. J Forensic Sci. 2018;63:954–7.

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Targeting S100A9 Prevents β-Adrenergic Activation–Induced Cardiac Injury;Inflammation;2024-03-06

2. Author Correction: α-Galactosylceramide and its analog OCH differentially affect the pathogenesis of ISO-induced cardiac injury in mice;Acta Pharmacologica Sinica;2021-11-16

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3